drugset / Trial / NCT03188276

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

NCT03188276

Non-randomizedSingle-groupOpen-labelPrevention

Summary

Hepatitis C virus (HCV) infection is easy to chronic and can progress to cirrhosis and liver cancer. Direct-acting antiviral treatment can significantly improve the prognosis of the disease and the efficacy is seemingly not affected by a variety of viral factors. In addition, direct-acting antiviral agents therapy may affect the transformation of the immune cells and ameliorate the host immune status consequently. This study mainly investigated the relationship between Direct Acting Antiviral Treatment effect and the functional activity of myeloid-derived suppressor cells (MDSCs) and natural killer cells (NK cells) in Chronic Hepatitis C.

Timeline

Start
2016-02-01
Primary completion
2017-05-01
Completion
2017-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Daclatasvir Small molecule 60 mg
Comparator Ledipasvir Small molecule 90 mg
Comparator Sofosbuvir Small molecule 400 mg